Literature DB >> 20183619

Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase.

Chengwei Li1, Brian G Gentry, John C Drach, Jiri Zemlicka.   

Abstract

Enantiomeric cyclopropavir phosphates (+)-9 and (-)-9 were synthesized and investigated as substrates for GMP kinase. N(2)-Isobutyryl-di-O-acetylcyclopropavir (11) was converted to (+)-monoacetate 12 using hydrolysis catalyzed by porcine liver esterase. Phosphorylation via phosphite 13 gave after deacylation, phosphate (+)-9. Acid-catalyzed tetrahydropyranylation of (+)-monoacetate 12 gave, after deacylation, tetrahydropyranyl derivative 14. Phosphorylation via phosphite 15 furnished, after deprotection, enantiomeric phosphate (-)-9. Racemic diphosphate 16 was also synthesized. The phosphate (+)-9 is a relatively good substrate for GMP kinase with a K(M) value of 57 microM that is similar to that of the natural substrates GMP (61 microM) and dGMP (82 microM). In contrast, the enantiomer (-)-9 is not a good substrate (K(M) 1200 microM) indicating a significant enantioselectivity for the GMP kinase catalyzed reaction of monophosphate to diphosphate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20183619      PMCID: PMC7976111          DOI: 10.1080/15257770903172720

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  16 in total

1.  Stereochemical considerations in the enzymatic phosphorylation and antiviral activity of acyclonucleosides. I. Phosphorylation of 2'-nor-2'-deoxyguanosine.

Authors:  J D Karkas; J Germershausen; R L Tolman; M MacCoss; A F Wagner; R Liou; R Bostedor
Journal:  Biochim Biophys Acta       Date:  1987-01-30

2.  In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.

Authors:  Earl R Kern; Nicole L Kushner; Caroll B Hartline; Stephanie L Williams-Aziz; Emma A Harden; Shaoman Zhou; Jiri Zemlicka; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Synthesis and enantioselectivity of the antiviral effects of (R,Z)-,(S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells.

Authors:  Y L Qiu; F Geiser; T Kira; E Gullen; Y C Cheng; R G Ptak; J M Breitenbach; J C Drach; C B Hartline; E R Kern; J Zemlicka
Journal:  Antivir Chem Chemother       Date:  2000-05

4.  Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity.

Authors:  Zhaohua Yan; Earl R Kern; Elizabeth Gullen; Yung-Chi Cheng; John C Drach; Jiri Zemlicka
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

5.  Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.

Authors:  Earl R Kern; Deborah J Bidanset; Caroll B Hartline; Zhaohua Yan; Jiri Zemlicka; Debra C Quenelle
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides.

Authors:  Y L Qiu; R G Ptak; J M Breitenbach; J S Lin; Y C Cheng; J C Drach; E R Kern; J Zemlicka
Journal:  Antiviral Res       Date:  1999-08       Impact factor: 5.970

7.  Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity.

Authors:  W H Miller; S M Daluge; E P Garvey; S Hopkins; J E Reardon; F L Boyd; R L Miller
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

8.  Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.

Authors:  Shaoman Zhou; Julie M Breitenbach; Katherine Z Borysko; John C Drach; Earl R Kern; Elizabeth Gullen; Yung-Chi Cheng; Jiri Zemlicka
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

9.  A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.

Authors:  V Sullivan; C L Talarico; S C Stanat; M Davis; D M Coen; K K Biron
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

10.  CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES.

Authors:  D E HOARD; D G OTT
Journal:  J Am Chem Soc       Date:  1965-04-20       Impact factor: 15.419

View more
  6 in total

1.  Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.

Authors:  Scott H James; Caroll B Hartline; Emma A Harden; Elizabeth M Driebe; James M Schupp; David M Engelthaler; Paul S Keim; Terry L Bowlin; Earl R Kern; Mark N Prichard
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.

Authors:  Han Chen; Chengwei Li; Jiri Zemlicka; Brian G Gentry; Terry L Bowlin; Donald M Coen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

3.  Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells.

Authors:  Brian G Gentry; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

4.  Filociclovir Is a Potent In Vitro and In Vivo Inhibitor of Human Adenoviruses.

Authors:  Karoly Toth; Islam T M Hussein; Ann E Tollefson; Baoling Ying; Jacqueline F Spencer; Jessica Eagar; Scott H James; Mark N Prichard; William S M Wold; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

5.  Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.

Authors:  Brian G Gentry; Jeremy P Kamil; Donald M Coen; Jiri Zemlicka; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

6.  Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.

Authors:  Nadine G Rouphael; Selwyn J Hurwitz; Mari Hart; Allison Beck; Evan J Anderson; Gregory Deye; Blaire Osborn; Shu Yi Cai; Chris Focht; Cyrille Amegashie; Terry L Bowlin; Jennifer Brooks; Mark J Mulligan
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.